Cargando...
Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidence of HCC and HCC-related deaths have increased over the last several decades. However, the treatment options for advanced HCC are very limited. Sorafenib remains the only drug approved for systemi...
Guardado en:
| Publicado en: | J Gastrointest Oncol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5401857/ https://ncbi.nlm.nih.gov/pubmed/28480065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.09.07 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|